Showing 241 - 260 results of 371 for search '"vaccines"', query time: 0.06s Refine Results
  1. 241

    Social network analysis of key stakeholders in Brucellosis prevention in Western Iran by Meysam Behzadifar, Mohammad Yarahmadi, Ahad Bakhtiari, Sahar Kargar, Saeed Shahabi, Samad Azari, Mariano Martini, Masoud Behzadifar

    Published 2025-02-01
    “…Economic constraints, such as the high cost of vaccines, along with limited public awareness, further hinder effective control efforts. …”
    Get full text
    Article
  2. 242
  3. 243

    Using the WHO building blocks to examine cross-border public health surveillance in MENA by Laura Buback, Shayanne Martin, Esbeydy Pardo, Farah Massoud, Jesus Formigo, Atousa Bonyani, Noha H. Farag, Zayid K. Almayahi, Kenta Ishii, Susie Welty, Dana Schneider

    Published 2025-02-01
    “…Recommendations emphasize strengthened governance and leadership to facilitate regional cooperation and information sharing, sustainable financing for implementing a One Health approach, utilizing innovative information systems, workforce development to enhance data collection and analysis, and secure supply chains for medicines and vaccines and equitable service delivery for all mobile populations. …”
    Get full text
    Article
  4. 244

    Nucleic Acid Aptamers for Human Norovirus GII.4 and GII.17 Virus-Like Particles (VLPs) Exhibit Specific Binding and Inhibit VLPs from Entering Cells by Cheng C, Sun M, Li J, Xue Y, Cai X, Liu J, Wang X, Xu S, Xie Y, Zhang J

    Published 2025-02-01
    “…Limited by laboratory culture, no vaccines or drugs have been developed against HuNoVs. …”
    Get full text
    Article
  5. 245
  6. 246

    Genetic characteristics of influenza A and B viruses circulating in Russia in 2019–2023 by Svetlana B. Yatsyshina, Anna A. Artamonova, Maria A. Elkina, Anna V. Valdokhina, Victoria P. Bulanenko, Aleksandra A. Berseneva, Vasily G. Akimkin

    Published 2024-12-01
    “…These viruses are monitored annually around the world, including Russia, to determine the dominant genetic groups and select the strains to be included in influenza vaccines. Objectives of the study include: analysis of influenza virus circulation in Russia in 2019–2023, phylogenetic and molecular analysis of hemagglutinin (HA) sequences of influenza viruses, detection of mutations associated with drug resistance to neuraminidase (NA) inhibitors and M2-protein (M2) ion channel inhibitors. …”
    Get full text
    Article
  7. 247
  8. 248

    Large-scale screening of HIV-1 T-cell epitopes restricted by 12 prevalent HLA-A allotypes in Northeast Asia and universal detection of HIV-1-specific CD8+ T cells by Yan Ding, Jialai Yan, Ling Huang, Jinhong Yu, Yandan Wu, Chuanlai Shen, Anning Fang

    Published 2025-02-01
    “…BackgroundAlthough the immune response of host T cells to human immunodeficiency virus (HIV) significantly influences the progression of the infection, the development of T-cell-based vaccines and therapies, as well as the clinical evaluation of specific T-cell functions, is currently markedly hindered by the absence of broad-spectrum, functionally validated HIV T-cell epitopes that account for the polymorphisms of the human leukocyte antigen (HLA) within an indicated geographic population. …”
    Get full text
    Article
  9. 249
  10. 250

    RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2 by Rang Feng, Ruo-Yi Xue, Chang Liu, Guo-Cheng Li, Yan Deng, Zhe Jin, Jing-Yi Liu, Shan-Shan Zhang, Hao Cheng, Man-Ying Guo, Quan-Ming Zou, Hai-Bo Li

    Published 2025-02-01
    “…Importantly, the induced antibodies effectively inhibited the binding of RBD to human angiotensin-converting enzyme 2 (hACE2) and neutralized SARS-CoV-2 pseudoviruses. Conclusions This vaccine platform offers an alternative strategy for developing recombinant subunit vaccines against SARS-CoV-2, potentially enhancing immune responses and improving vaccine efficacy. …”
    Get full text
    Article
  11. 251
  12. 252

    Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah... by Mokhtar JA, Attallah DM, Jiman-Fatani AA, Al-Rabia MW, Alqarni MA, Saleh BH, Amboon MM, Altorki TA, Alkuwaity KK, Abujamel T, Kaki R, Albarakati TN, Daghistani H, Ismail MA, Alharbi O, Abu ITM, Alfadil A, Ibrahem K, Mufrrih M, Sait AM

    Published 2025-02-01
    “…Jawahir A Mokhtar,1– 3 Dalya M Attallah,2 Asif Ahmad Jiman-Fatani,1,2 Mohammed W Al-Rabia,1 Mona Abdulrahman Alqarni,1 Bandar Hasan Saleh,1,2 Maysaa Mohammed Amboon,4 Tarfa A Altorki,3,4 Khalil K Alkuwaity,3,4 Turki Abujamel,3,4 Reham Kaki,5,6 Taghreed Nassir Albarakati,7 Hussam Daghistani,8,9 Mazen A Ismail,10 Ohood Alharbi,11 Ibrahim Ismail Mohammed Abu,12 Abdelbagi Alfadil,1,13 Karem Ibrahem,1,2 Mohammed Mufrrih,4,14 Ahmad M Sait4,9 1Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Department of Clinical Microbiology Laboratory, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia; 3Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 4Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 5Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 6Department of Infectious Disease & Infection Control and Environmental Health, King Abdulaziz University Hospital, Jeddah, Saudi Arabia; 7Microbiology Unite in King Fahd General hospital Jeddah (KFHJ), Jeddah, Saudi Arabia; 8Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University Jeddah, Jeddah, 21589, Saudi Arabia; 9Regenerative Medicine Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 10Department of Medical Education, Faculty of Medicine, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 11Department of Microbiology and Parasitology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia; 12Department of Community Medicine, Faculty of medicine, King Abdulaziz University, Jedda, 21589, Saudi Arabia; 13Centre of Research Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah, Saudi Arabia; 14Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaCorrespondence: Karem Ibrahem, Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, P.O. …”
    Get full text
    Article
  13. 253

    Factors Affecting Immunization Coverage for Children Under Five Years in Rwanyamahembe Sub-County, Mbarara District- Uganda. by Omia, Santos

    Published 2023
    “…The study further identified inadequate funding of the program, perceived shortage of staff, cost of vaccination and vaccination cards, inadequate supply of vaccine stock, inadequate vaccination sites and corruption and embezzlement of funds as the main institutional factors affecting with EPI service coverage. …”
    Get full text
    Thesis
  14. 254

    A Mathematical Model For The Dynamics of Polio. by Owobusingye, Johnan

    Published 2024
    “…There is a lack of treatment for poliomyelitis and it is only prevented through immunization with live oral polio vaccine (OPV) or/and inactivated polio vaccine (IPV). …”
    Get full text
    Thesis
  15. 255
  16. 256

    QAAPT: an interoperable web-based open-source tool for antimicrobial resistance data analysis and visualisation by Mohammad Julhas Sujan, Sanjay Gautam, Ahmed Taha Aboushady, Adam Clark, Sooyoung Kwon, Hea Sun Joh, Marianne Holm, John Stelling, Florian Marks, Florian Marks, Florian Marks, Florian Marks, Nimesh Poudyal

    Published 2025-02-01
    “…The QAAPT tool was created by the Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia project, led by the International Vaccine Institute (IVI). This open-source web-based tool/application generates statistical and visual outputs of AMR data, offers data curation options, and can be integrated with laboratory information management systems. …”
    Get full text
    Article
  17. 257

    Clinical course, management and outcomes of COVID-19 in HIV-infected renal transplant recipients: A case series by L Bertels, K Manning, A Redd, T du Toit, Z Barday, E Muller

    Published 2024-04-01
    “…All the COVID‐19‐positive patients had at least one comorbidity. Vaccination data were available for 24 patients, of whom 5 had refused SARS‐CoV‐2 vaccination. …”
    Get full text
    Article
  18. 258

    Epidemiological investigation of poultry infectious in Kazakhstan (2021–2024) by Karlygash B. Zikibayeva, Asset A. Svanbayev, Nurlan N. Akhmetsadykov, Kamshat N. Kudaibergenova, Shynar N. Akhmetsadykova, Ernur N. Nurolda, Aidyn I. Kydyrmanov

    Published 2025-02-01
    “…Using official data, laboratory diagnostics, and surveys, we identified high prevalence rates and virulent strains, exposing gaps in vaccination coverage and biosecurity practices. Continuous monitoring, improved vaccination strategies, and robust biosecurity measures are essential to reduce disease impact and ensure sustainable poultry farming.MethodsA cross-sectional study was conducted to assess the prevalence and genetic diversity of major avian infectious diseases in Kazakhstan. …”
    Get full text
    Article
  19. 259

    Unvaccinated COVID-19 Pneumonia- a family affair by Trilok Stead, Michael Hughes, Frank Fraunfelter, Vashun Rodriguez, Latha Ganti

    Published 2022-04-01
    “…This case illustrates the complexities of vaccine hesitancy and societal misinformation.…”
    Get full text
    Article
  20. 260